Block Inc. receives positive assessment from Bernstein with increased EBITDA projections and improved operational discipline. Sustained growth expected.
Investment banking firm Jefferies raises Eli Lilly's price target based on optimism over orfoscerinib, indicating strong confidence in its potential. ...